Bitmine owns 4.8% of the total ETH coin supply of 120.7 millionBitmine is 96% of the way to the 'Alchemy of 5%' in just 13 monthsBitmine repurchased 6.1 million common...

JOHANNESBURG, July 27, 2026 /PRNewswire/ -- At the Huawei Network Summit 2026 South Africa, Huawei unveiled its upgraded Xinghe AI Campus Solution for the Southern Africa region under the "Secure...

JOHANNESBURG, July 27, 2026 /PRNewswire/ -- At the Huawei Network Summit 2026 South Africa, Huawei unveiled its upgraded Xinghe AI Campus Solution for the Southern Africa region under the "Secure...

Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. Offers 5x greater sensitivity vs. in-class instruments with...

Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology.Offers 5x greater sensitivity vs. in-class instruments with lower...

Regulatory dossiers for Replexor Active submitted in Brazil and Australia; US and Argentina to follow in 2027Rounding out weed control spectrum, Replexor Active strengthens integrated PPO herbicide portfolio, helping growers...

Expanded Network: The interline partnership seamlessly connects Air Premia's long-haul U.S. routes with cities across more than 40 countries served by Jeju Air. Seamless Travel: Single-ticket itineraries enhance passenger convenience; joint travel...

Regulatory dossiers for Replexor Active submitted in Brazil and Australia; US and Argentina to follow in 2027 Rounding out weed control spectrum, Replexor Active strengthens integrated PPO herbicide portfolio, helping...

CHENGDU, China, July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received a clinical trial notice from the Center for...

CHENGDU, China, July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received a clinical trial notice from the Center for...